1. Aberrant DNA methylation in multiple myeloma: A major obstacle or an opportunity?
    Catharina Muylaert et al, 2022, Frontiers in Oncology CrossRef
  2. Downregulation of miR-152 contributes to DNMT1-mediated silencing of SOCS3/SHP-1 in non-Hodgkin lymphoma
    Qing-Ming Wang et al, 2019, Cancer Gene Therapy CrossRef
  3. Effects of siRNA Livin on EJ human bladder cancer cells treated with mitomycin-C
    YA-HUI SONG et al, 2015, Oncology Letters CrossRef
  4. Epigenetic silencing of EVL/miR-342 in multiple myeloma
    Zhenhai Li et al, 2018, Translational Research CrossRef
  5. LncRNA MIR210HG promotes the proliferation, migration, and invasion of lung cancer cells by inhibiting the transcription of SH3GL3
    Fang Zou et al, 2023, The Kaohsiung Journal of Medical Sciences CrossRef
  6. LncRNA NEAT1 Interacted With DNMT1 to Regulate Malignant Phenotype of Cancer Cell and Cytotoxic T Cell Infiltration via Epigenetic Inhibition of p53, cGAS, and STING in Lung Cancer
    Fang Ma et al, 2020, Frontiers in Genetics CrossRef
  7. Targeting aberrant DNA methylation in mesenchymal stromal cells as a treatment for myeloma bone disease
    Antonio Garcia-Gomez et al, 2021, Nature Communications CrossRef
  8. Epigenetic-modifying agents: The potential game changers in the treatment of hematologic malignancies
    Tahereh Hojjatipour et al, 2024, Critical Reviews in Oncology/Hematology CrossRef
  9. DNMT3B silencing suppresses migration and invasion by epigenetically promoting miR-34a in bladder cancer
    Kai Xu et al, 2020, Aging CrossRef
  10. Combination treatment with doxorubicin and microRNA-21 inhibitor synergistically augments anticancer activity through upregulation of tumor suppressing genes
    SHANSHAN ZHANG et al, 2015, International Journal of Oncology CrossRef
  11. A novel hypoxia-selective epigenetic agent RRx-001 triggers apoptosis and overcomes drug resistance in multiple myeloma cells
    D Sharma Das et al, 2016, Leukemia CrossRef
  12. Epigenetic modifications in multiple myeloma: recent advances on the role of DNA and histone methylation
    Nicola Amodio et al, 2017, Expert Opinion on Therapeutic Targets CrossRef
  13. Organic cation transporter 2 activation enhances sensitivity to oxaliplatin in human pancreatic ductal adenocarcinoma
    Ching-Feng Chiu et al, 2022, Biomedicine & Pharmacotherapy CrossRef
  14. Decoding DNA methylation in epigenetics of multiple myeloma
    Ting Yang et al, 2022, Blood Reviews CrossRef